Home About Us Professional Student Public Search Contact Us
Dental Practice Support

Back

Oral Manifestations of HIV

Importance of oral healthcare for HIV positive patients
Oral manifestations of HIV disease are common and include oral lesions and novel presentations of previously known opportunistic diseases. Careful history taking and detailed examination of the patient's oral cavity are important parts of the physical examination and diagnosis requires appropriate investigative techniques. Early recognition, diagnosis and treatment of HIV-associated oral lesions may reduce morbidity.

The presence of these lesions may be an early diagnostic indicator of immunodeficiency and HIV infection, may change the classification of the stage of HIV infection and is a predictor of the progression of HIV disease. In addition a poorly functional dentition can adversely affect the quality of life, further compromising the health of the HIV afflicted patients, many of whom may already be malnourished

Fungal Lesions

Candidiasis

Oral candidiasis is most commonly associated with Candida albicans, although other species, such as C. glabrata and C. tropicalis, are frequently part of the normal oral flora. A number of factors predispose patients to develop candidiasis: infancy, old age, antibiotic therapy, steroid and other immunosuppressive drugs, xerostomia, anaemia, endocrine disorders, and primary and acquired immunodeficiency. Candidiasis is a common finding in people with HIV infection. Reports describe oral candidiasis during the acute stage of HIV infection, but it occurs most commonly with falling CD4 + T-cell count in middle and late stages of HIV disease.

Clinical Features

The clinical appearances of oral candidiasis vary. The most common presentations include pseudomembranous and erythematous candidiasis, which are equally predictive of the development of AIDS and angular cheilitis. These lesions may be associated with a variety of symptoms, including a burning mouth, problems eating spicy food and changes in taste All three of these common forms may appear in one individual.
  • Pseudomembranous Candidiasis (Thrush)
    Characteristic creamy white, removable plaques on the oral mucosa are caused by overgrowth of fungal hyphae mixed with desquamated epithelium and inflammatory cells. The mucosa may appear red when the plaque is removed. This type of candidiasis may involve any part of the mouth or pharynx.
  • Erythematous Candidiasis
    Erythematous candidiasis appears as flat, red patches of varying size. It commonly occurs on the palate and the dorsal surface of the tongue. Erythematous candidiasis is frequently subtle in appearance and clinicians may easily overlook lesions, which may persist for several weeks if untreated.
  • Angular Cheilitis
    Angular cheilitis appears clinically as redness, ulceration and fissuring, either unilaterally or bilaterally at the corners of the mouth. It can appear alone or in conjunction with another form of candidiasis.
  • Hyperplastic Candidiasis
    This type of candidiasis is unusual in persons with HIV infection. The lesions appear white and hyperplastic. The white areas are due to hyperkeratosis and unlike the plaques of pseudomembranous candidiasis, cannot be removed by scraping. These lesions may be confused with hairy leukoplakia. Diagnosis of hyperplastic candidiasis is made from the histologic appearance of hyperkeratosis and the presence of hyphae. Periodic acid-Schiff (PAS) stain is often used to demonstrate hyphae.

Differential Diagnosis

Erythematous candidiasis should be differentiated from other red lesions, such as Kaposi's sarcoma or erythroplakia. Histologically, oral candidiasis contains Candida hyphae in the superficial epithelium when viewed under a PAS stain. The inflammatory responses often associated with Candida infection may be absent in immunocompromised patients. The creamy white plaques of pseudomembranous candidiasis are removable; the white lesions of hairy leukoplakia are nonremovable.

Diagnosis

Candida is a commensal organism in the oral cavity. Candidiasis is diagnosed by its clinical appearance and by detection of organisms on smears. Smears taken from clinical lesions are examined using potassium hydroxide (KOH), PAS or Gram's stain. Smears are taken by gently drawing a wooden tongue depressor across the lesion. The specimen is then transferred into a drop of KOH on a glass slide and protected by a cover slip. The smear is examined under the microscope and Candida is detected by finding hyphae and blastospores. Hyphae and spores are only seen in smears from lesions and are rarely seen in the healthy individual in the carrier state. Cultures are grown on specific media, such as Sabouraud's agar; they may be positive and yet reveal very low colony counts. This probably represents a carrier state rather than active infection. Culture is useful for establishing the Candida species but may not be useful for diagnosis.

Treatment

Oral candidiasis may be treated either topically or systemically. Treatment should be maintained for 7 days. Response to treatment is often good; oral lesions and symptoms may disappear in a fairly short period (ranging from 2 to 5 days), but relapses are common because of the underlying immunodeficiency. As with other causes of oral candidiasis, recurrences are common if the underlying problem persists.
  • Topical Treatment
    Topical treatments are preferred because they limit systemic absorption, but the effectiveness depends entirely on patient compliance. Topical medications require that the patient hold medications in the mouth for 20 to 30 minutes. If the patient uses formulations containing sweetening agents for long periods, consider as concurrent treatment daily fluoride rinses (e.g., ACT or Fluorigard, available as over-the-counter preparations) for 1 minute once a day and then expectorated.
    Clotrimazole is an effective topical treatment (one oral troche [10-mg tablet]) when dissolved in the mouth five times daily. Used less frequently, one vaginal troche can be dissolved in the mouth daily. Nystatin preparations include a suspension, a vaginal tablet and an oral pastille. Regimens are nystatin vaginal tablets (one tablet, 100,000 units, dissolved in the mouth three times a day) or nystatin oral pastille (available as a 200,000-unit oral pastille, one or two pastilles dissolved slowly in the mouth five times a day). Nystatin suspension has a high sugar content and cannot be held in the mouth long enough to be effective. Topical creams and ointments containing nystatin, ketoconazole or clotrimazole may be useful in treating angular cheilitis. Another therapeutic choice is amphotericin B (0.1 mg/ml). Five to 10 ml of oral solution is used as a rinse and then expectorated three to four times daily.
  • Systemic Treatment
    Several agents are effective for systemic treatment. Ketoconazole (Nizoral) is a 200-mg tablet taken with food once daily. Patient compliance is usually good. Careful monitoring of liver function is necessary for long-term use because of reported side effects, including hepatotoxicity. Lack of efficacy of ketoconazole may occur because of poor absorption in those with an abnormally high gastric pH.
    Fluconazole (Diflucan) is a triazole antifungal agent effective in treating candidiasis (100-mg tablet taken once daily for 2 weeks). Itraconazole (100-mg capsules) may be used for the treatment of oral candidiasis (200 mg daily orally for 14 days). Itraconazole oral suspension is now available (200 mg daily for 2 weeks). Salivary levels of Itraconazole are maintained for several hours after administration.
    Ketoconazole, fluconazole and itraconazole may interact with other medications including rifampicin, phenytoin, cyclosporin A, terfenadine, digoxin, coumarin-like medications and oral hypoglycemic medications.

Prognostic Significance

Both erythematous and pseudomembranous oral candidiasis are associated with increased risk for the subsequent development of opportunistic infections classifying the patient as having AIDS as defined by the Centers for Disease Control (CDC).Several studies have shown a statistical correlation between frequency of oral candidiasis in HIV infection and falling CD4 + T-cell counts.

Histoplasmosis

Histoplasmosis is an infection caused by the fungus. Histoplasma Capsulatum

Clinical Features

  • 30-50% with disseminated histplasmosis may present with oral lesions.
  • Oral lesions appear with ill defined margins and a granulomatous surface appearance.
  • Cervical and submandibular lymphadenopathy is a feature.
  • Gingival involvement often mimics severe periodontal disease.
  • Diagnosis requires biopsy and histological examination of the specimen.

Treatment

  • Patient should be referred to HIV specialist.
  • Oral lesion scan be treated with ketoconazole and amphotericin preparations.

Cryptococcus Neoformans

Clinical Features

  • Nearly 10% of patients with cryptococcus develop lesions on the skin of the head and neck region.
  • Oral lesions are rare, when they do occur, oral lesions are ulcerative.
  • Cryptococcus in AIDS patients is a fatal condition.
  • A biopsy, histological examinations and tissue culture can confirm the diagnosis.

Treatment

  • Ketoconazole and amphotericin B are the drugs of choice.
Viral lesions

Herpes Simplex

Herpes simplex causes both primary and secondary or recurrent disease in the oral cavity. Primary herpetic gingivostomatitis commonly occurs in children and young adults and may be followed by frequent recurrences. Following the primary episode, the virus becomes latent in the trigeminal ganglion. Recurrent oral herpes occurs at any age extraorally or intraorally.

Clinical Features

Recurrent herpes labialis occurs on the vermilion border of the lips. The patient may report a history of itching or pain, followed by the appearance of small vesicles. These rupture and form crusts. Recurrent intraoral herpes appears as clusters of painful small vesicles that rupture and ulcerate and usually heal within 1 week to 10 days. The lesions usually occur on the keratinized mucosa, such as the hard palate and gingiva, although lesions may arise on the dorsal surface of the tongue.

Differential Diagnosis

Rising antibody titers from initial and convalescent sera confirm primary herpetic gingivostomatitis. Examining smears of lesions (treated with Papanicolaou stain) for multinucleated giant cells confirms recurrent herpes. It is possible to demonstrate herpes simplex type 1 or type 2 by applying monoclonal antibodies to smears from the lesions Swabs taken from fluid-filled vesicles may grow herpes simplex in culture if vesicles are a few days or less old. Clinicians can distinguish between recurrent intraoral herpes simplex lesions, which always occur on keratinized mucosa (such as the hard palate and gingiva), and recurrent aphthous ulcers, which always appear on nonkeratinized mucosa. Recurrent intraoral herpes may appear more frequently in HIV-infected patients. The lesions may be painful and slow to heal.

Treatment

No treatment will permanently eradicate oral herpes simplex infections, but acyclovir may shorten the healing time for individual episodes. The optimum oral dosage of acyclovir is 1,000 to 1600 mg daily for 7 to 10 days. Topical acyclovir is not useful for treating intraoral lesions and may not be effective for lesions on the lips. Recurrent outbreaks of acyclovir-resistant herpes have been reported; the lesions can be treated with foscarnet. Phosphonoformate may also prove effective.

Prognostic Significance

There is no known association between recurrent intraoral herpes and more rapid progression of HIV disease. However, there is a clinical impression that recurrent herpes simplex infections may be more common in patients with symptomatic HIV disease.

Herpes Zoster

The reactivation of varicella zoster virus (VZV) causes herpes zoster (shingles). The disease occurs in the elderly and the immunosuppressed.

Clinical Features

Oral herpes zoster generally causes skin lesions. Following a prodromal of pain, multiple vesicles appear on the facial skin, lips and oral mucosa. Skin and oral lesions are frequently unilateral and follow the distribution of the maxillary and/or mandibular branches of the trigeminal nerve. The skin lesions form crusts and the oral lesions coalesce to form large ulcers. The ulcers frequently affect the gingiva, so tooth pain may be an early complaint.

Differential Diagnosis

The appearance of the lesions and their distribution are pathognomonic.

Treatment

Acyclovir limits the duration of the lesions. For herpes zoster, the standard oral dosage is 800 mg five daily for 7 to 10 days, which is considerably higher than that recommended for treatment of herpes simplex.

Human Papillomavirus Lesions

Oral warts, papillomas, skin warts and genital warts are associated with the human papillomavirus (HPV). Lesions caused by HPV are common on the skin and mucous membranes of persons with HIV disease. Anal warts have frequently been reported among homosexual men. Because the HPV types found in oral lesions in HIV-infected persons are different from the HPV types associated with anogenital warts, clinicians should probably not use the term condyloma acuminata to describe oral HPV lesions.

Clinical Features

HPV lesions in the oral cavity may appear as solitary or multiple nodules. They may be sessile or pedunculated and appear as multiple, smooth-surfaced raised masses resembling focal epithelial hyperplasia or as multiple, small papilliferous or cauliflower-like projections.

Differential Diagnosis

A biopsy is necessary for histologic diagnosis.

Prognosis

There is no known association between oral HPV lesions and more rapid progression of HIV disease, but oral warts are seen more commonly in HIV- infected persons than in the general population.

Treatment

Oral HPV lesions can be removed surgically using local anesthetic. Carbon dioxide laser surgery can remove multiple flat warts, but relapses occur and several repeat procedures may be necessary.

Cytomegalovirus

Oral ulcers caused by cytomegalovirus (CMV) have been reported. These ulcers can appear on any mucosal surface and may be confused with aphthous ulcers, necrotizing ulcerative periodontitis (NUP) and lymphoma. Unlike aphthous ulcers, however, which usually have an erythematous margin, CMV ulcers appear necrotic with a white halo. Diagnosis of CMV ulcers is made from a biopsy. Immunohistochemistry may be helpful. CMV ulcers in the oral cavity usually occur in individuals with disseminated CMV disease. Therefore, diagnosis of CMV-infected oral ulcers should be followed by examination for the systemic disease. CMV ulcers resolve when ganciclovir is used to treat CMV disease.

Hairy Leukoplakia and Epstein-Barr Virus

Oral hairy leukoplakia (HL), which presents as a nonmovable, corrugated or "hairy" white lesion on the lateral margins of the tongue, occurs in all risk groups for HIV infections, although less commonly in children than in adults. HL occurs in about 20% of persons with asymptomatic HIV infection and becomes more common as the CD4 + T-cell count falls. HL is in group 4, category C2 of the original Centers for Disease Control (CDC) definition of AIDS and in B3 of the 1993 criteria. No report describes HL in mucosal sites other than the mouth.HL has occurred in non-HIV-infected people including recipients of bone marrow, cardiac and renal transplants.

Hairy Leukoplakia and Progression of HIV Disease

Diagnosis of HL is an indication of both HIV infection and immunodeficiency; it is an indication for a work-up to evaluate and treat HIV disease. HL correlates with a statistical risk for more rapid progression of HIV disease. In an early study, 30% of persons with HL progressed to late-stage HIV disease characterized by CDC-defined AIDS within 36 months. In a later study, 47% of a group developed CDC-defined AIDS within 2 years and 67% within four years.Those persons with HL who progressed to CDC-defined AIDS most rapidly, however, were more often anergic to Candida antigen at diagnosis of HL, indicating significant immunosuppression at that time. Progression to CDC- defined AIDS was more rapid in those HIV-infected persons with HL than in those without HL, even after adjustment for CD4 + T-cell count.

Pathogenesis

The Epstein-Barr virus (EBV) in HL is both unusual in that deletions in the EBNA 2 gene have been described and till date no viral DNA is found in the basal layers of HIV. Intraepithelial Langerhans' cells (LCs) are reduced or absent in the HL lesion, which correlates with the presence of viral antigens. It is not known whether the lack of LCs is a cause of HL or a consequence of EBV infection.

Clinical Appearance and Manifestations

HL lesions vary in size and appearance and may be unilateral or bilateral. The surface is irregular and may have prominent folds or projections, sometimes markedly resembling hairs. Occasionally, however, some areas may be smooth and flat. Lesions occur most commonly on the lateral margins of the tongue and may spread to cover the entire dorsal surface . They may also spread downward onto the ventral surface of the tongue, where they usually appear flat. HL lesions can also occur on the buccal mucosa, generally as flat lesions. Rarely, lesions occur on the soft palate. HL usually does not cause symptoms.

Differential Diagnosis

Candida albicans may be found in association with many HL lesions and hyphae can be seen in specimens taken from lesions and examined using potassium hydroxide. Hyphae can be seen in sections stained with periodic acid- Schiff. Administration of antifungal drugs may change the appearance of the lesions but does not cause them to disappear. Clinicians must distinguish them from other white lesions, such as lichen planus, idiopathic leukoplakia, white sponge nevus, dysplasia and squamous cell carcinoma.

Diagnosis

HL should be diagnosed by biopsy for definitive diagnosis. Experienced clinicians can make a presumptive diagnosis of HL in association with HIV disease from the clinical appearance, although HL can be confused with oral candidiasis. The typical microscopic appearance of HL includes acanthosis, marked parakeratosis with the formation of ridges and keratin projections, areas of ballooning cells and little or no inflammation in the connective tissue. The ballooning changes resemble koilocytosis. Cells are enlarged; some contain enlarged ballooning cells with pyknotic nuclei. Some contain perinuclear haloes. Definitive diagnosis of HL requires demonstration of EBV. EBV may be readily demonstrated in biopsy specimens by a variety of techniques. Cells taken from the HL lesion by scraping can be used for a noninvasive diagnosis using in situ hybridization.

Treatment

Hairy leukoplakia usually is asymptomatic and does not require treatment. HL is almost always a manifestation of HIV infection and clinicians should arrange evaluation of HIV disease and appropriate treatment for patients with HL. HL has disappeared in patients receiving high-dose acyclovir for herpes zoster, presumably because of the anti- EBV activity of acyclovir. Doses of acyclovir (2.5 to 3 mg per day for 2 to 3 weeks) usually eliminate HL, but the lesion usually recurs with cessation of treatment. Elimination or almost complete clinical resolution of the lesion has occurred in patients treated with agents such as desciclovir, an analog of acyclovir,(55) phosphonoformate, Retin A and podophyllin resin, although lesions tend to recur within a few months. Occasionally, Candida albicans may be found in HL lesions. Treatment consists of antifungal medications.
Bacterial Lesions

Periodontal Disease

Periodontal disease is a fairly common problem in both asymptomatic and symptomatic HIV-infected patients. It can take two forms: The rapid and severe condition called necrotizing ulcerative periodontitis (NUP) and its associated and possibly precursor condition called linear gingival erythema (LGE). The presenting clinical features of these diseases often differ from those in non-HIV-infected persons.

Clinical Features

LGE and NUP often occur in clean mouths where there is very little plaque or calculus to account for the gingivitis. The onset is often sudden, with rapid loss of bone and soft tissue. In LGE, the gingiva may be reddened and edematous. Patients sometimes complain of spontaneous bleeding. In acute-onset ulcerative gingivitis, ulcers occur at the tips of the interdental papilla and along the gingival margins and often elicit complaints of severe pain. The ulcers heal, leaving the gingival papillae with a characteristic cratered appearance. NUP may present as rapid loss of supporting bone and soft tissue. Typically, these losses occur simultaneously with no formation of gingival pockets, sometimes involving only isolated areas of the mouth. Teeth may loosen and eventually fall out, but uninvolved sites can appear healthy. Necrotizing stomatitis may develop and areas of necrotic bone may appear along the gingival margin. The bone may eventually sequestrate. Patients with NUP and necrotizing stomatitis frequently complain of extreme pain and spontaneous bleeding.

Differential Diagnosis

The patient's history and clinical appearance help in making the diagnosis. It is sometimes difficult to distinguish this type of periodontal disease from non-HIV-related periodontal disease. However, the complaints of severe pain, rapid onset, and rapid destruction in an often extremely clean mouth are unusual for non- HIV-related periodontal disease.

Treatment

The following protocol has achieved reasonable success: Plaque removal, local debridement, irrigation with povidone-iodine, scaling and root planing, and maintenance with a chlorhexidine mouth rinse (Peridex-R) once or twice daily. Studies show that the addition of chlorhexidine to this regimen produces significant improvement in periodontal condition. In cases of NUP, metronidazole (one 250-mg tablet four times daily), amoxicillin/clavulanate (Augmentin)(one 250-mg tablet three times daily) or clindamycin (one 300-mg tablet three times daily) should be added to the treatment regimen

Different Course in HIV Infection

The microbiology of periodontal disease in HIV-infected patients has not been fully described. Oral flora associated with LGE and NUP appear to be similar to those associated with periodontal disease seen in non- HIV-infected persons. Recurrences of acute episodes are common and response to conventional treatment may be poor. However, therapeutic strategies and frequent recall appointments can produce effective local treatment of LGE and NUP. There is as yet no known relationship between these conditions and the progression of HIV disease.

Mycobacterium Avium Intracellulare

Mycobacterium avium-intracellulare has been reported to have presented as palatal and gingival granulomatous masses in the oral cavity. A diagnosis requires biopsy specimen of acid fast bacilli cultured from blood and sputum and a special stain.
Neoplastic Lesions

Kaposi's Sarcoma

Kaposi's sarcoma (KS) may occur intraorally, either alone or in association with skin and disseminated lesions. Intraoral lesions have been reported at other sites and may be the first manifestation of late-stage HIV disease (AIDS). KS occurs most commonly in men but also has been observed in women.

Clinical Features

KS can appear as a red, blue or purplish lesion. It may be flat or raised, solitary or multiple. The most common oral site is the hard palate, but lesions may occur on any part of the oral mucosa, including the gingiva, soft palate and buccal mucosa, and in the oropharynx. Occasionally, yellowish mucosa surrounds the KS lesion. Oral KS lesions may enlarge, ulcerate and become infected. Good oral hygiene is essential to minimize these complications.

Differential Diagnosis

KS must be distinguished from vascular lesions such as hematomas, hemangiomas, other vascular tumours, pyogenic granulomas, bacillary angiomatosis,(69) and pigmented lesions such as oral melanotic macules. Diagnosis is made from histologic examination.(70,71) There are usually no bleeding problems associated with a biopsy of oral KS. However, aspiration of a lesion prior to biopsy may be useful to rule out a hemangioma. Small, flat lesions are probably in early stages and the histologic appearance is different from the larger, nodular lesions that are probably more advanced. Early lesions may be difficult to diagnose histologically because they resemble endothelial proliferation. KS may appear suddenly, within days of a normal oral examination, in previously uninvolved areas of the mouth. Providers should ensure that a patient with KS receives evaluation and follow-up care for the underlying HIV disease.

Treatment

Treatment is determined on the basis of the number, size and location of the oral KS lesions. The choice of therapy depends on the effect of treatment on the adjacent mucosa, pain associated with treatment, interference with eating and speaking and the patient's preference. It is important to perform thorough dental prophylaxis before initiating therapy for KS lesions involving the gingiva. Response to therapy is improved if all local plaque and calculus are removed. Local application of sclerosing agents may reduce the size of oral lesions.

Local treatment is appropriate for large oral KS lesions that interfere with eating and talking. Oral KS can be treated surgically or with localized intralesional chemotherapy. Surgical removal is suitable for small, well- circumscribed lesions such as gingival or tongue lesions. Surgical removal can be performed under local anesthesia with a blade or with the carbon dioxide laser. Intralesional vinblastine is useful for treating small lesions, particularly on the palate or gingiva. Several studies have documented the effectiveness of one or two injections of 0.1 to 0.2 mg per ml solution of vinblastine. Post treatment pain is fairly common, but systemic effects are rare. The pain usually disappears several days after therapy.

Radiation therapy may be indicated for large, multiple lesions. A single dose of 800 cGy or an equivalent fractionated dose is frequently used and produces a good response. Side effects include xerostomia and mucositis, although both conditions usually improve with cessation of radiation therapy.

Lymphoma

Clinical Features

Diffuse, undifferentiated non-Hodgkin's lymphoma (NHL) is a frequent HIV-associated malignancy. Most are of B cell origin, and Epstein-Barr virus occurs in cells from several cases. Lymphoma can occur anywhere in the oral cavity and there may be soft tissue involvement with or without involvement of underlying bone. The lesion may present as firm, painless swelling that may be ulcerated. Some oral lesions may appear as shallow ulcerations. Oral NHL may appear as solitary lesions with no evidence of disseminated disease.

Differential Diagnosis

Oral NHL may be confused with major aphthous ulcers and rarely as a pericoronitis associated with an erupting third molar. Diagnosis of NHL must be made by histologic examination of biopsy specimens.

Treatment

After diagnosis of the oral lesions, the patient must be referred for further evaluation for disseminated disease and its subsequent treatment.
Other Lesions Associated with HIV

Oral Ulcerations

Other Oral Lesions Associayed With HIV Disease

Oral ulcers resembling recurrent aphthous ulcers (RAUs) in HIV-infected persons are reported with increasing frequency. The cause of these ulcers is unknown. Proposed causes include stress and unidentified infectious agents. In HIV-infected patients, the ulcers are well circumscribed with erythematous margins.

The ulcers can be classified as:

  • The minor RAU type may appear as solitary lesions of about 0.5 to 1.0 cm.
  • The herpetiform type appear as clusters of small ulcers (1 to 2 mm), usually on the soft palate and oropharynx.
  • The major RAU type appears as extremely large (2 to 4 cm) necrotic ulcers. The major RAUs are very painful and may persist for several weeks.

Diagnosis

The ulcers may present a diagnostic problem. Herpetiform RAUs may resemble the lesions of coxsackievirus infection and major RAUs may require biopsy to exclude malignancy, such as lymphoma or opportunistic infection, such as histoplasmosis. The ulcers usually occur on nonkeratinized mucosa; this characteristic differentiates them from those caused by herpes simplex.

Treatment

The RAU type ulcers usually respond well to topical steroids such as fluocinonide (0.05%) ointment mixed with equal parts Orabase applied six times daily or clobetasol (0.05%) ointment mixed with equal parts Orabase applied three times per day. Dexamethasone elixir (0.5 mg/5 ml) used as a mouth rinse and then expectorated two to three times daily is helpful for multiple ulcers and for those where topical ointments are hard to apply. For HIV- infected persons with oral and gastrointestinal aphthous-like ulcers, systemic steroid therapy (prednisone 40 to 60 mg/day for 7 to 10 days) has been reported as helpful. The risks of steroid therapy, however, must be considered before administration to individuals in this population. Top

Thrombocytopenic Purpura

Reports have described idiopathic thrombocytopenic purpura (ITP) in HIV-infected patients. Oral lesions may be the first manifestation of this condition.

Clinical Features

Petechiae, ecchymoses and hematoma can occur anywhere on the oral mucosa. Spontaneous bleeding from the gingiva can occur and patients may report finding blood in their mouth on waking.

Differential Diagnosis

The clinician must distinguish ITP from other vascular lesions and KS. Because of potential bleeding risk, the clinician should obtain blood and platelet counts before performing other diagnostic procedures. Top

Salivary Gland Diseases and Xerostomia

Salivary gland disease associated with HIV infection (HIV-SGD) can present as xerostomia with or without salivary gland enlargement. Reports describe salivary gland enlargement in children and adults with HIV infection usually involving the parotid gland. The enlarged salivary glands are soft but not fluctuant. In some cases, enlarged salivary glands may be due to lymphoepithelial cysts. Schiodt et al. found that 9 of 12 patients (11 adults and 1 child) with HIV-SGD had salivary gland enlargement. Three had xerostomia. Labial salivary gland biopsy revealed histologic features similar to those in Sjogren's syndrome. In HIV-SGD, however, the lymphocytic infiltrate is predominantly CD8 cells, unlike that in Sjogren's syndrome, which is predominantly CD4 cells. No evidence of Epstein-Barr virus or cytomegalovirus has been found in biopsies of salivary glands. One report describes an association between HIV-SGD and HLA-DR5 and HLA-B35 cell-surface antigen. The etiology of HIV-SGD is as yet unknown but the enlarged parotid glands can be a source of annoyance and discomfort. Xerostomia is sometimes seen in individuals with HIV-SGD. HIV-infected patients may also experience dry mouth in association with taking certain medications that can hinder salivary secretion, such as antidepressants, antihistamines and anti anxiety drugs.

Management

Removal of the enlarged parotid glands is rarely recommended. For individuals with xerostomia, the use of salivary stimulants such as sugarless gum or sugarless candies may provide relief. Candies that are acidic should be avoided as frequent use may lead to loss of tooth enamel. The use of salivary substitutes may also be helpful. An increase in caries can occur, so fluoride rinses (that can be bought over the counter) should be used daily, and visits to the dentist should be recommended two to three times per year.